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Abstract
Background: Periaqueductal gray (PAG) is a substantial descending pain modulatory center, and previous voxel-based
morphometry study confirmed the clusters with increased volume in PAG region in medication-overuse headache
(MOH). The aim of this study is to investigate altered PAG volume in MOH using an automated PAG segment method
to measure the true PAG volume.
Methods: High resolution three-dimensional T1-weighted fast spoiled gradient recalled echo MR images were obtained
from 22 patients with MOH and 22 normal controls (NC). PAG template was created based on ICBM 152 gray template,
and the individual PAG was generated by applying the deformation field from structural image segment to the PAG
template, and individual PAG volume was calculated.
Results: There was a significant increased volume of PAG in MOH (0.366 ± 0.005 ml) than that in NC (0.341 ± 0.
005 ml)(P < 0.05). There was no significant correlation between the PAG volume and the clinical variables in MOH
patients (P > 0.05). The area of receiver operating characteristic (ROC) curve was 0.845, and the cut-off of PAG
volume was 0.341 ml with sensitivity 95.5% and specificity 63.6%.
Conclusion: The present study demonstrated that the PAG volume gain was confirmed in MOH patients, and the
automated individual PAG volume measure may be considered as a simple and effective imaging biomarker in
MOH diagnosis.
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Background
Periaqueductal gray (PAG) was an anatomic and func-
tional interface between forebrain and brainstem, and
PAG was classified into 4 columns with different cyto-
architecture and included multiple types of neurons (eg.
L-glutamate,γ-aminobutyric acid (GABA), opioids (par-
ticularly enkephalin), substance P) [1]. The PAG columns
had distinct connections with the forebrain, brainstem,
and nociceptive neurons of lamina I of the spinal cord and
trigeminal nucleus [2–4]. PAG is a critical component of a
network that is activated in response to pain, and the
different PAG columns receive functionally segregated
input from nociceptive pathways [5–7]. Previous studies
demonstrated that PAG activation was modulated by
expectation of pain [8] and placebo analgesia [9].
PAG is a substantial descending pain modulatory cen-
ter, which exerts a dual control (including inhibition and
facilitation) on nociceptive transmission in the dorsal
horn and trigeminal nucleus [10], and the modulatory
mechanism was exerted by descending PAG-RVM
(rostral ventromedial medulla) pathway contributing to
central sensitization and development of secondary hyper-
algesia [10, 11]. PAG dysfunction was recognized in
migraine [12], and functional MRI studies demonstrated
that the PAG dysfunction was associated with increased
iron deposition, which may play a role in the genesis or
pathophysiology of MOH [13–15].
In the previous studies, the conventional MR imaging
demonstrated that specific lesion such as multiple sclerosis
and infarction in PAG may produced the migraine-like
symptoms [16–21]. and nonspecific lesions without definite
clinical diagnosis in PAG region [22]. Voxel-based morph-
ometry (VBM) powerfully demonstrated that the clusters
with PAG volume increase in MOH [23] and the clusters
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with PAG volume reducement in MOH with detoxification
treatment response [24]. Therefore, PAG volume changes
become an important imaging variable in MOH for the
diagnosis and the treatment assessment.
VBM methods commonly could compare groups of
individuals, and it also could be used to compare single
case with control groups although a very high false posi-
tive rates presents [25] and non-parametric statistics could
addressing the problem of high false positive rate in single
case VBM [26]. As these methods were performed over
the whole brain level, an automated individual PAG
volume measurement was applied to MOH patients in the
current study, and the expected cut-off value of PAG
volume would be provided for the MOH diagnosis.
Methods
Subjects
Written informed consent was obtained from all partici-
pants according to the approval of the ethics committee
of the local institutional review board. Twenty-two MOH
patients were recruited from the International Headache
Center, Department of Neurology, Chinese PLA General
Hospital. All the following inclusion criteria should be
fulfilled: 1) diagnosis of 8.2 MOH, and 1.1 and 1.2
migraine based on the International Classification of
Headache Disorders, third Edition (beta version) (ICHD-
III beta) [27]; 2) no migraine preventive medication used
in the past 3 months; 3) age between 20 and 60 years; 4)
right-handed; 5) patient’s willingness to engage in the
study. The exclusion criteria were the following: 1) with any
chronic disorders, including hypertension, hypercholester-
olemia, diabetes mellitus, cardiovascular diseases, cerebro-
vascular disorders, neoplastic diseases, infectious diseases,
connective tissue diseases, other subtypes of headache,
chronic pain other than headache, severe anxiety or depres-
sion preceding the onset of headache, psychiatric diseases,
etc.; 2) with alcohol, nicotine, or other substance abuse;
3) with cranium trauma, illness interfering with central
nervous system function, psychotic disorder, and regular
use of a psychoactive or hormone medication. Twenty-two
normal controls (NCs) were recruited from the hospital’s
staff and their relatives. Inclusion criteria were similar to
those of patients, except for the first two items. NCs should
never have had any primary headache disorders or other
types of headache in the past year. General demo-
graphic and headache information were registered and
evaluated in our headache database. Additionally, we
evaluated anxiety, depression, and cognitive function of
all the participants by using the Hamilton Anxiety Scale
(HAMA) [28], the Hamilton Depression Scale (HAMD)
[29], and the Montreal Cognitive Assessment (MoCA)
Beijing Version (www.mocatest.org). The study proto-
col was approved by the Ethical Committee of Chinese
PLA General Hospital and complied with the Declaration
of Helsinki. Informed consent was obtained from all
participants before the study. MRI scans were taken in the
interictal stage at least three days after a migraine attack
for MOH patients. All the patients were given with the
Visual Analogue Scale (VAS). All the subjects were right-
handed and underwent conventional MRI examination to
exclude the subjects with cerebral infarction, malacia, or
occupying lesions. Alcohol, nicotine, caffeine, and other
substances were avoided for at least 12 h before MRI
examination.
MRI acquisition
Images were acquired on a GE 3.0 T MR system
(DISCOVERY MR750, GE Healthcare, Milwaukee, WI,
USA) and a conventional eight-channel quadrature
head coil was used. All subjects were instructed to
lie in a supine position, and formed padding was used
to limit head movement. A three-dimensional T1-
weighted fast spoiled gradient recalled echo (3D T1-
FSPGR) sequence generating 180 contiguous axial slices
[TR (repetition time) = 6.3 ms, TE (echo time) = 2.8 ms,
flip angle = 15o, FOV (field of view) = 25.6 cm× 25.6 cm,
Matrix = 256 × 256, NEX (number of acquisition) = 1] was
used to perform the new segment and the individual
PAG creation. Conventional T2-weighted imaging (T2WI)
and T1 fluid-attenuated inversion recovery (T1-FLAIR)
weighted imaging were also acquired. All imaging proto-
cols were identical for all subjects. No obvious structural
damage and T2-visible lesion were observed based on the
conventional MR images.
MR image processing
All MR structural image data were processed using
Statistical Parametric Mapping 12 (SPM 12) (http://
www.fil.ion.ucl.ac.uk/spm/) running under MATLAB
7.6 (The Mathworks, Natick, MA, USA) to perform
segment [30]. The image processing included following steps:
(1) Create PAG template based on mni_icbm152_gm_
tal_nlin_asym_09a template by pen tool using MRIcron
software (www.mricro.com); (2) Individual PAG segment by
apply the deformation field (generated by segment) to
the PAG template using the runback strategy; (3) cal-




The statistical analysis was performed by using PASW
Statistics 18.0. The significance differences of PAG volume
between MOH group and NC group were computed
using general linear model (independent univariate t-test
with age and sex as covariates). The Pearson's correlation
analysis was applied between PAG volume and the clinical
variables in MOH. The age, HAMA, HAMD and MoCA
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were performed with independent samples T test, and sex
was performed with Chi-Square test. Significant difference
was set at a P value of < 0.05. Receiver operating charac-
teristic (ROC) curve analysis was performed to identify
the diagnostic efficacy and the cut-off value of PAG volume
for MOH.
Results
Demography and neuropsychological test
Twenty-two MOH patient (F/M = 14/8) and 22 NCs
(F/M = 14/4) were enrolled (Table 1). There was no
significant difference for age and sex between MOH
(42.55 ± 10.31 years old) and NC (45.09 ± 10.50 years
old). There was significant difference for the scores of
HAMA, HAMD and MoCA in MOH compared with
that in NC (P < 0.05). The disease duration was 6.65 ±
8.00 years, and the scores of VAS were 8.27 ± 1.52.
The type of overused medication in MOH patients
included:simple analgesics (3/22), simple triptans (1/22),
and combination analgesics (18/22).
Comparison of PAG volume between MOH group and NC
group
There was a significant increased volume of PAG in
MOH (0.366 ± 0.005 ml) than that in NC (0.341 ±
0.005 ml)(F value = 14.41, P value = 0.000) (Fig. 2). There
Fig. 1 The flow chart of PAG template and individual PAG segmentation. Top line: PAG template was created using MRIcron software based
standard MNI template (left 3 columns); Bottom line: Individual PAG segment was performed using New segment tool (SPM8 software) and then
applied the generated deformation field to PAG template to generate individual PAG. Red and blue represent 3D visualization of PAG template
and individual PAG
Table 1 The clinical characteristics of MOH patients and normal
controls(NC)
MOH NC T value P value
Num(F/M) 22(14/8) 22(19/3) 3.03a 0.16
Age(yrs) 42.55 ± 10.31 45.09 ± 10.50 0.81 0.42
HAMA 15.82 ± 6.81 9.77 ± 3.15 3.78 0.00
HAMD 17.91 ± 8.88 8.09 ± 4.80 4.54 0.00
MoCA 24.23 ± 3.21 27.50 ± 1.97 4.08 0.00
DD(yrs) 6.65 ± 8.00 NA NA NA
VAS 8.27 ± 1.52 NA NA NA
NA Not available, DD disease duration
aChi-Square test
Fig. 2 PAG volume distribution plot of MOH and NC
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was no significant correlation between the PAG volume
and the clinical variables in MOH patients (P > 0.05).
ROC analysis between MOH group and NC group
The area of receiver operating characteristic (ROC) curve
was 0.845, and the cut-off of PAG volume was 0.341 ml
with sensitivity 95.5% and specificity 63.6% (Fig. 3).
Discussion
PAG dysfunction had been identified in MOH patients,
and the investigation methods including resting-state
functional MRI [31–33], diffusion kurtosis imaging [34],
positron emission tomography [35], and iron deposition
study [13]. The altered PAG function [33] may result in
the change of PAG volume. The previous VBM study
identified clusters in PAG region with volume increase
[36], which was based on normalized grey matter. How-
ever, the current study provided the true individual PAG
volume change firstly in vivo.
The present findings demonstrated the PAG volume
gain in MOH compared with NC, which may explain
the PAG dysfunction in MOH from the PAG structural
pathophysiological change viewpoint. However, the cor-
relation analysis showed that there was no any signifi-
cant correlation between the PAG volume and the
clinical variables in MOH patients. These findings sug-
gested that PAG volume gain may only be associated
with the descending pain modulatory network, and the
other clinical factor such as anxiety, depress and cogni-
tive function could not influence the PAG structural
change in MOH although anxiety scores, depression
scores showed significant difference between MOH and
NC. The previous study [37] indicated that anxiety and
depression scores was correlated with gray matter
volumes of some cerebral regions, therefore, it could
assume that anxiety and depression might impair the
cerebral regions, and PAG volume gain might be specific
change in MOH patients.
Although PAG volume gain was identified in MOH
in this study, Fig. 2 present a small overlap between
MOH and NC for PAG volume. Further ROC analysis
demonstrated PAG volume measurement showed a
good level for the diagnosis of MOH from NC. The
cut-off value of PAG volume (0.341 ml) could provide
a high sensitivity (95.5%), however, the specificity
(63.6%) was relative. Therefore, it should be careful to
explain the diagnosis of MOH when PAG volume
around the cut-off value.
Compared with VBM study, the current study
employed an automated PAG volume measurement.
VBM study was generally used to compare the difference
between groups, and individual PAG volume could not
be measured by this method. In this study, the individual
PAG segment was generated by applying the deform-
ation filed to the PAG template, which also be recog-
nized as pull back strategy. This automated PAG
measurement method could be performed in the rou-
tine clinical practice, and had a widespread application
for MOH diagnosis, even for the treatment response as-
sessment. However, it should be more prudent when
PAG volume was considered as a biomarker for the
diagnosis of MOH since MOH is likely to remain a
clinical diagnosis.
The limits for this study included as follows: (1)
The sample was relative small, and the large sample
of MOH and NC should be needed in the future
study; (2) The present study was a cross-sectional
study, and the longitudinal observation and the treatment
response evaluation should further be performed in
future study.
Conclusion
In conclusion, PAG volume gain was identified in MOH
patients, and PAG volume may be considered as an
imaging biomarker for the diagnosis of MOH.
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